Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Clinical and Vaccine Immunology : CVI|May 18, 2012
A human papillomavirus (HPV) in vitro neutralization assay that recapitulates the in vitro process of infection provides a sensitive measure of HPV L2 infection-inhibiting antibodiesPatricia M Day, Yuk-Ying S Pang, Rhonda C Kines, et al.Journal of Virology|June 8, 2007
Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibitionPatricia M Day, Cynthia D Thompson, Christopher B Buck, et al.Cell Host & Microbe|September 14, 2010
In vivo mechanisms of vaccine-induced protection against HPV infectionPatricia M Day, Rhonda C Kines, Cynthia D Thompson, et al.NPJ Vaccines|November 20, 2025
Post-attachment neutralization of HPV16 by antibodies derived from Gardasil-vaccinated womenPatricia M Day, Cynthia D Thompson, Erin M Scherer, et al.Journal of Virology|November 13, 2015
A Cell-Free Assembly System for Generating Infectious Human Papillomavirus 16 Capsids Implicates a Size Discrimination Mechanism for Preferential Viral Genome PackagingCarla Cerqueira, Yuk-Ying S Pang, Patricia M Day, et al.Journal of Virology|September 27, 2013
Characterization of Mus musculus papillomavirus 1 infection in situ reveals an unusual pattern of late gene expression and capsid protein localizationAlessandra Handisurya, Patricia M Day, Cynthia D Thompson, et al.Journal of Virology|May 17, 2019
Human Papillomavirus 16 Capsids Mediate Nuclear Entry during InfectionPatricia M Day, Andrea S Weisberg, Cynthia D Thompson, et al.Journal of Virology|December 28, 2005
A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomesNadine Kämper, Patricia M Day, Thorsten Nowak, et al.Virology|September 19, 2012
Murine skin and vaginal mucosa are similarly susceptible to infection by pseudovirions of different papillomavirus classifications and speciesAlessandra Handisurya, Patricia M Day, Cynthia D Thompson, et al.The Journal of Clinical Investigation|November 13, 2012
Intravaginal immunization with HPV vectors induces tissue-resident CD8+ T cell responsesNicolas Çuburu, Barney S Graham, Christopher B Buck, et al.Pageof 5